HUP0101603A3 - Cephalosporines having cyclic aminoguanidine substituents, process for their preparation, pharmaceutical compositions thereof and intermediates - Google Patents

Cephalosporines having cyclic aminoguanidine substituents, process for their preparation, pharmaceutical compositions thereof and intermediates

Info

Publication number
HUP0101603A3
HUP0101603A3 HU0101603A HUP0101603A HUP0101603A3 HU P0101603 A3 HUP0101603 A3 HU P0101603A3 HU 0101603 A HU0101603 A HU 0101603A HU P0101603 A HUP0101603 A HU P0101603A HU P0101603 A3 HUP0101603 A3 HU P0101603A3
Authority
HU
Hungary
Prior art keywords
cephalosporines
intermediates
substituents
preparation
pharmaceutical compositions
Prior art date
Application number
HU0101603A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of HUP0101603A2 publication Critical patent/HUP0101603A2/hu
Publication of HUP0101603A3 publication Critical patent/HUP0101603A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU0101603A 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents, process for their preparation, pharmaceutical compositions thereof and intermediates HUP0101603A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0051598A AT406772B (de) 1998-03-23 1998-03-23 Antibakterielle 7-acylamino-3-iminomethyl- cephalosporine und verfahren zu deren herstellung
PCT/EP1999/001853 WO1999048896A1 (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents as antibiotics

Publications (2)

Publication Number Publication Date
HUP0101603A2 HUP0101603A2 (hu) 2001-12-28
HUP0101603A3 true HUP0101603A3 (en) 2002-10-28

Family

ID=3492649

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0101603A HUP0101603A3 (en) 1998-03-23 1999-03-19 Cephalosporines having cyclic aminoguanidine substituents, process for their preparation, pharmaceutical compositions thereof and intermediates

Country Status (25)

Country Link
US (1) US6440957B1 (enExample)
EP (2) EP1930335A1 (enExample)
JP (1) JP2002507616A (enExample)
KR (1) KR100696422B1 (enExample)
CN (1) CN1188418C (enExample)
AR (1) AR015248A1 (enExample)
AT (1) AT406772B (enExample)
AU (1) AU749735B2 (enExample)
BR (1) BR9908960A (enExample)
CA (1) CA2324953C (enExample)
CO (1) CO5080739A1 (enExample)
HU (1) HUP0101603A3 (enExample)
ID (1) ID26567A (enExample)
IL (2) IL138477A0 (enExample)
MY (1) MY119841A (enExample)
NO (1) NO20004760L (enExample)
NZ (1) NZ506908A (enExample)
PE (1) PE20000360A1 (enExample)
PL (1) PL343094A1 (enExample)
RU (1) RU2245884C2 (enExample)
SK (1) SK14152000A3 (enExample)
TR (1) TR200002749T2 (enExample)
TW (1) TWI250983B (enExample)
WO (1) WO1999048896A1 (enExample)
ZA (1) ZA200004850B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6693095B2 (en) * 1997-04-01 2004-02-17 Biochemie Gesellschaft M.B.H. Antibacterial substituted 7-acylamino-3-(methylhydrazono) methyl-cephalosporins and intermediates
DE102007052891A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Stabilisierung von olefinisch ungesättigten Monomeren
DE102013204950A1 (de) 2013-03-20 2014-09-25 Evonik Industries Ag Verfahren und Zusammensetzung zur Inhibierung der Polymerisation von Cyclopentadienverbindungen
ES2624415T3 (es) 2014-09-08 2017-07-14 Evonik Degussa Gmbh (Tio)acetales fenólicos como agentes inhibidores de la polimerización de monómeros olefínicamente insaturados
TWI669317B (zh) 2014-09-22 2019-08-21 德商贏創德固賽有限責任公司 反應性單體的改良製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE943408C (de) * 1953-03-31 1956-05-17 Bayer Ag Verfahren zur Darstellung von Bisguanylhydrazonen
FI851934A7 (fi) * 1984-05-30 1985-12-01 Ici Plc Kefalosporiinijohdannaisia.
GB8721568D0 (en) * 1987-09-14 1987-10-21 Fujisawa Pharmaceutical Co Cephem compounds
NZ308518A (en) * 1995-05-11 2000-01-28 Biochemie Gmbh Antibacterial cephalosporins
NZ337732A (en) * 1997-04-01 2001-09-28 Biochemie Gmbh Antibacterial substituted 7-acylamino -3-(methylhydrazono) methyl-cephalosporins and intermediates

Also Published As

Publication number Publication date
EP1082326A1 (en) 2001-03-14
ZA200004850B (en) 2002-02-27
JP2002507616A (ja) 2002-03-12
ID26567A (id) 2001-01-18
KR100696422B1 (ko) 2007-03-20
WO1999048896A1 (en) 1999-09-30
AR015248A1 (es) 2001-04-18
TR200002749T2 (tr) 2000-12-21
PE20000360A1 (es) 2000-05-17
CO5080739A1 (es) 2001-09-25
SK14152000A3 (sk) 2001-05-10
CA2324953C (en) 2008-05-13
AU749735B2 (en) 2002-07-04
AT406772B (de) 2000-08-25
CN1294593A (zh) 2001-05-09
NO20004760L (no) 2000-11-21
KR20010074666A (ko) 2001-08-08
IL138477A (en) 2007-06-17
NZ506908A (en) 2003-04-29
RU2245884C2 (ru) 2005-02-10
CN1188418C (zh) 2005-02-09
PL343094A1 (en) 2001-07-30
MY119841A (en) 2005-07-29
ATA51598A (de) 2000-01-15
US6440957B1 (en) 2002-08-27
AU3518899A (en) 1999-10-18
HUP0101603A2 (hu) 2001-12-28
IL138477A0 (en) 2001-10-31
NO20004760D0 (no) 2000-09-22
TWI250983B (en) 2006-03-11
CA2324953A1 (en) 1999-09-30
EP1930335A1 (en) 2008-06-11
BR9908960A (pt) 2000-12-05

Similar Documents

Publication Publication Date Title
HUP0102307A3 (en) Bispidine derivatives, process for their preparation, pharmaceutical compositions thereof and intermediates
HUP0302257A3 (en) 4-hydrazino-5-hydroxy-5-pyrazol derivatives, pharmaceutical compositions containing them, process for producing them and their intermediates
HUP0102723A3 (en) New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0104582A3 (en) 1,2-annelated quinoline derivatives, pharmaceutical compositions thereof, intermediates and process for their preparation
PL345162A1 (en) Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
PL344412A1 (en) Pyrazoline derivatives, their preparation and application as medicaments
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0202762A3 (en) Solid lipid compositions, process for their preparation and use thereof
IL140897A0 (en) Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0102602A3 (en) Diacylhydrazine derivatives, method for their preparation, their use and pharmaceutical compositions comprising thereof
HUP0105108A3 (en) Amide compounds, process for their preparation and pharmaceutical compositions containing them
PL349448A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
HUP0102732A3 (en) Substituted amids, their use for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0303118A3 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
IL137332A (en) Benzothiadiazoles and derivatives, their preparation and pharmaceutical compositions comprising them
HUP0203471A3 (en) Antithrombotic compound, process for their preparation, pharmaceutical compositions containing them and their use
ZA9610460B (en) New phenylamidine derivatives, processes for preparing them and their use as pharmaceutical compositions.
AU2001292331A2 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
HUP0103316A3 (en) 2-ureido-pyrimidone derivatives, method for producing them, pharmaceutical compositions containing them and their use
HUP0201785A3 (en) Dihydrobenzodiazepins, process for producing them, their use and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
GB9A Succession in title

Owner name: NABRIVA THERAPEUTICS FORSCHUNGS GMBH, AT

Free format text: FORMER OWNER(S): BIOCHEMIE GMBH., AT; SANDOZ AG, CH

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished